Precigen
PGEN
#5008
Rank
โ‚น185.30 B
Marketcap
โ‚น519.78
Share price
0.37%
Change (1 day)
280.29%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -โ‚น18.14 Billion

According to Precigen's latest financial reports the company's current earnings are โ‚น31.59 Million. In 2025 the company made an earning of -โ‚น24.04 Billion a decrease over its 2024 earnings that were of -โ‚น12.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น18.14 Billion-24.55%
2025 -โ‚น24.04 Billion95.77%
2024 -โ‚น12.28 Billion32.86%
2023 -โ‚น9.25 Billion20.5%
2022 -โ‚น7.67 Billion-23.33%
2021 -โ‚น10.01 Billion60.11%
2020 -โ‚น6.25 Billion-65.1%
2019 -โ‚น17.91 Billion-65.19%
2018 -โ‚น51.43 Billion313.44%
2017 -โ‚น12.44 Billion-33.2%
2016 -โ‚น18.62 Billion123.22%
2015 -โ‚น8.35 Billion1.47%
2014 -โ‚น8.23 Billion109.54%
2013 -โ‚น3.93 Billion-50.04%
2012 -โ‚น7.86 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-โ‚น0.24 Billion-98.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-โ‚น7.01 Billion-64.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น6.19 Billion-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-โ‚น14.27 Billion-27.22% Jersey